ACCESS Consortium Expands Focus To ATMPs And ‘Urgently Needed’ Medicines

A work-sharing group made up of regulators in Australia, Canada, Singapore, Switzerland and the UK has been expanded to include advanced therapy medicinal products, which could lead to greater harmonization in the regulatory approaches taken by different agencies.